It has been proposed that they act via the expression of the transcription factor STAT3, whereby they produce cytokines to promote a tumor-supportive environment by suppressing the proliferation of anti-tumor CD4+ and CD8+ T cells and promoting the activity of regulatory CD4+ T cells [20]. The gene discussed is CD8A; the disease is neoplasm.